Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 14Anorexia 9Endometrial Hyperplasia 7Cachexia 7Neoplasms 5Breast Neoplasms 4Overweight 2Obesity 2Body Weight Changes 2Weight Loss 1Turcot syndrome 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Recurrence 1Prosthesis Failure 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Oligodendroglioma 1Nutrition Disorders 1Neoplasms, Second Primary 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Medulloblastoma 1Lymphoma 1Lung Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Accelerated Phase 1

Interventions

Radiotherapy 1Paclitaxel 1Olanzapine 1Megestrol Acetate 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Prosthesis Failure × Megestrol Acetate × Clear all
NCT06500234 2024-07-15

Nutrition Impact on Immunotherapy of Cancer

Qingdao Central Hospital

Phase 3 Recruiting
300 enrolled

Neoplasms, Nutrition Disorders, Prosthesis Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡